REGIONAL CHEMOTHERAPY TO THE CANINE LIVER WITH 5-FLUOROURACIL (5FU) AND ADRIAMYCIN (AM)

被引：0
|
作者：
KARAKOUSIS, CP [1 ]
SHARMA, SD [1 ]
KANTER, P [1 ]
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1982年 / 23卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [41] Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor - In reply
    White, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4268 - 4269
  • [42] Does the dose of leucovorin (LV) matter with 5-fluorouracil (5FU) in colorectal cancer (CRC)?
    Biagi, James Joseph
    Coakley, Nadia
    Earle, Craig
    Erlichman, Charles
    Fields, Anthony L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [43] AN INTERMITTENT LEUCOVORIN CALCIUM (LV) 5-FLUOROURACIL (5FU) REGIMEN FOR ADVANCED ADENOCARCINOMA OF THE COLON
    BRUCKNER, HW
    HART, R
    SPIGELMAN, M
    FEUER, R
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 202 - 202
  • [44] CONTINUOUS 5-FLUOROURACIL (5FU) INFUSION IN CARCINOMA OF THE PANCREAS - A PHASE-II STUDY
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    CHITAMBAR, C
    ANDERSON, T
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 295 (02): : 91 - 93
  • [45] Hepatic arterial chemotherapy (HAC) with oxaliplatin (OXA), leucovorin (LV) and 5-fluorouracil (5FU): A feasible and effective regimen.
    Del Freo, DFAA
    Lombardi, M
    Mambrini, A
    Muttini, MP
    Pennucci, MC
    Sanguinetti, F
    Torri, T
    Cantore, M
    ANNALS OF ONCOLOGY, 2006, 17
  • [46] In vivo modulation of 5-fluorouracil (5FU) pharmacokinetics by eniluracil, and inactivator of dihydropyrimidine dehydrogenase (DPD)
    Saleem, A
    Abaogye, EO
    Yap, J
    Osman, S
    Purnell, C
    O'Callaghan, M
    Lucas, VS
    Jones, T
    Price, PM
    BRITISH JOURNAL OF CANCER, 1999, 80 : 94 - 94
  • [47] Use of methylation profiling to identify predictive markers in gastric cancer for respond to 5-fluorouracil (5FU)-based chemotherapy.
    Liem, N.
    Lim, P.
    Loh, M.
    Vaithilingham, A.
    Soong, R. C.
    Yong, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] RESULTS OF INTRAOPERATIVE 5-FLUOROURACIL (5FU) SUPPLEMENTATION ON TRABECULECTOMY SURGERY FOR OPEN ANGLE GLAUCOMA
    SMITH, MF
    SHERWOOD, MB
    DOYLE, JW
    KHAW, PT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1393 - 1393
  • [49] CHEMOTHERAPY OF ADVANCED CARCINOMA OF PROSTATE WITH 5-FLUOROURACIL, CYCLOPHOSPHAMIDE AND ADRIAMYCIN
    MERRIN, C
    ETRA, W
    WAJSMAN, Z
    BAUMGARTNER, G
    MURPHY, G
    JOURNAL OF UROLOGY, 1976, 115 (01): : 86 - 88
  • [50] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
12345